Publication:
Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method

dc.contributor.authorBoontida Morakulen_US
dc.contributor.authorJiraphong Suksiriworapongen_US
dc.contributor.authorMullika Traidej Chomnawangen_US
dc.contributor.authorPeter Langguthen_US
dc.contributor.authorVaraporn Burapacheep Junyapraserten_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherJohannes Gutenberg Universitat Mainzen_US
dc.date.accessioned2018-11-09T01:55:49Z
dc.date.available2018-11-09T01:55:49Z
dc.date.issued2014-01-01en_US
dc.description.abstract© 2014 Elsevier B.V. All rights reserved. The gastroduodenal diseases caused by Helicobacter pylori were commonly treated with antibiotic clarithromycin as a standard regimen. According to the poorly water-soluble of clarithromycin, the nanocrystal formulation was prepared. The aim of this study was to investigate an enhancement effect of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization (PLH) method on the saturation solubility, dissolution velocity, antibiotic activity, permeability through the gastric mucus and cellular permeability. Poloxamer 407 and sodium lauryl sulfate (SLS) were chosen as combined stabilizers in the nanocrystal system. The obtained clarithromycin nanocrystals were identified as cubic particles by SEM with a bulk population of approximately 400 nm existed in crystalline and/or partial amorphous form as investigated by DSC and XRPD. The saturation solubility of the clarithromycin nanocrystals was increased by 1.5- and 6-folds higher than clarithromycin powder in buffer pH 5.0 and 6.8, respectively. The dissolution profiles of clarithromycin nanocrystals at pH 5.0 and 6.8 were significantly different from clarithromycin powder and the marketed product (f<inf>1</inf> value >15 and f<inf>2</inf> value <50). All dissolution parameters (relative dissolution rate, percent dissolution efficiency and mean dissolution time) showed that clarithromycin nanocrystals had higher dissolution rate when compared with the clarithromycin powder, the lyophilized coarse suspension and the marketed product. The bioassay study by diffusion agar method showed a maintained antibiotic activity of clarithromycin nanocrystals solubilized in buffer solution which was greater potency than the lyophilized coarse suspension and the clarithromycin powder. Additionally, the nanocrystals possessed higher permeability through gastric mucus and cellular monolayer of Caco-2 and NCI-N87 cells as compared to the lyophilized coarse suspension and the clarithromycin powder. The results indicated that, the developed clarithromycin nanocrystals were a potential delivery system that exerts more effectiveness in H. pylori eradication.en_US
dc.identifier.citationEuropean Journal of Pharmaceutics and Biopharmaceutics. Vol.88, No.3 (2014), 886-896en_US
dc.identifier.doi10.1016/j.ejpb.2014.08.013en_US
dc.identifier.issn18733441en_US
dc.identifier.issn09396411en_US
dc.identifier.other2-s2.0-84912130946en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/33347
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84912130946&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleDissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization methoden_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84912130946&origin=inwarden_US

Files

Collections